Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Find your ideal API manufacturing partner in high-growth markets globally List available now!

Carbidopa; Levodopa Patent Expiration

Carbidopa; Levodopa is Used for treating Parkinson's disease and related conditions such as post-encephalitic parkinsonism and parkinsonism from carbon monoxide or manganese intoxication. It was first introduced by Organon Llc A Sub Of Organon And Co in its drug Sinemet on Approved Prior to Jan 1, 1982. Other drugs containing Carbidopa; Levodopa are Sinemet Cr, Duopa, Dhivy, Crexont, Rytary. 29 different companies have introduced drugs containing Carbidopa; Levodopa.


Carbidopa; Levodopa Patents

Given below is the list of patents protecting Carbidopa; Levodopa, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Crexont US11986449 Levodopa dosing regimen Dec 21, 2041 Impax
Crexont US12109185 Levodopa dosing regimen Dec 21, 2041 Impax
Crexont US12194150 Levodopa dosing regimen Dec 21, 2041 Impax
Crexont US12201596 Levodopa dosing regimen Dec 21, 2041 Impax
Dhivy US11033521 Levodopa fractionated dose composition and use Mar 28, 2039 Avion Pharms
Dhivy US11439613 Levodopa fractionated dose composition and use Mar 28, 2039 Avion Pharms
Dhivy US11819485 Levodopa fractionated dose composition and use Mar 28, 2039 Avion Pharms
Crexont US10098845 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof Oct 07, 2034 Impax
Crexont US10292935 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof Oct 07, 2034 Impax
Crexont US10688058 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof Oct 07, 2034 Impax
Crexont US10973769 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof Oct 07, 2034 Impax
Crexont US10987313 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof Oct 07, 2034 Impax
Crexont US11357733 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof Oct 07, 2034 Impax
Crexont US11622941 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof Oct 07, 2034 Impax
Crexont US11666538 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof Oct 07, 2034 Impax
Crexont US12064521 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof Oct 07, 2034 Impax
Crexont US12128141 Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof Oct 07, 2034 Impax
Crexont US12178918 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof Oct 07, 2034 Impax
Crexont US12178919 Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof Oct 07, 2034 Impax
Rytary US8377474 Controlled release formulations of levodopa and uses thereof Dec 26, 2028 Impax
Rytary US8454998 Controlled release formulations of levodopa and uses thereof Dec 26, 2028 Impax
Rytary US8557283 Controlled release formulations of levodopa and uses thereof Dec 26, 2028 Impax
Rytary US9089607 Controlled release formulations of levodopa and uses thereof Dec 26, 2028 Impax
Rytary US9089608 Controlled release formulations of levodopa and uses thereof Dec 26, 2028 Impax
Rytary US9463246 Controlled release formulations of levodopa and uses thereof Dec 26, 2028 Impax
Rytary US9533046 Controlled release formulations of levodopa and uses thereof Dec 26, 2028 Impax
Rytary US9901640 Controlled release formulations of levodopa and uses thereof Dec 26, 2028 Impax
Rytary US7094427 Combination immediate release controlled release levodopa/carbidopa dosage forms May 29, 2022

(Expired)

 Impax



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Carbidopa; Levodopa's patents.

Given below is the list recent legal activities going on the following patents of Carbidopa; Levodopa.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 03 Jul, 2024 US9533046
Payment of Maintenance Fee, 8th Year, Large Entity 11 Apr, 2024 US9463246(Litigated)
Email Notification
Critical
 24 May, 2023 US8377474(Litigated)
Change in Power of Attorney (May Include Associate POA)
Critical
 24 May, 2023 US8377474(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 30 Jan, 2023 US9089607(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 30 Jan, 2023 US9089608(Litigated)
Payment of Maintenance Fee, 4th Year, Large Entity 11 Aug, 2021 US9901640
Payment of Maintenance Fee, 8th Year, Large Entity 31 Mar, 2021 US8557283(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 25 Sep, 2020 US8454998(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 06 Aug, 2020 US8377474(Litigated)


Carbidopa; Levodopa's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Carbidopa; Levodopa Generic API Manufacturers

Several generic applications have been filed for Carbidopa; Levodopa. The first generic version for Carbidopa; Levodopa was by Dr Reddys Laboratories Sa and was approved on Aug 28, 1992. And the latest generic version is by Ascent Pharmaceuticals Inc and was approved on Jan 14, 2025.

Given below is the list of companies who have filed for Carbidopa; Levodopa generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 2 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG; 100MG

tablet, extended release Prescription ORAL AB Feb 8, 2013
50MG; 200MG

tablet, extended release Prescription ORAL AB Feb 8, 2013





2. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 3 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG; 250MG

(reference standard)

tablet Prescription ORAL AB Sep 3, 1993
25MG; 100MG

tablet Prescription ORAL AB Sep 3, 1993
10MG; 100MG

tablet Prescription ORAL AB Sep 3, 1993


Manufacturing Plant Locations
New

Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.

Country City Firm Name
United States
Elizabeth Actavis Elizabeth LLC, A Company of Teva





3. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG; 100MG

tablet, extended release Prescription ORAL AB Jun 5, 2019
50MG; 200MG

tablet, extended release Prescription ORAL AB Jun 5, 2019


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Panelav Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd
Panchmahal Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)
Vadodara Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals, Ltd





4. ANI PHARMS

Ani Pharmaceuticals Inc has filed for 3 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Ani Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG; 250MG

tablet Discontinued ORAL N/A Jun 29, 1995
25MG; 100MG

tablet Discontinued ORAL N/A Jun 29, 1995
10MG; 100MG

tablet Discontinued ORAL N/A Jun 29, 1995





5. APOTEX

Apotex Inc has filed for 2 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG; 200MG

tablet, extended release Prescription ORAL AB Jun 16, 2004
25MG; 100MG

tablet, extended release Prescription ORAL AB Jun 16, 2004


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Winnipeg Apotex Fermentation Inc.
Etobicoke Apotex, Inc.
Toronto Apotex Inc.
Richmond Hill Apotex Inc.
Brantford Apotex Pharmachem Inc.
North York Apotex Inc.
India
Bengaluru Apotex Research Private Limited
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bangalore Apotex Pharmachem India Pvt Ltd.





6. APOTEX INC

Apotex Inc has filed for 3 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Apotex Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG; 100MG

tablet Prescription ORAL AB Jun 2, 2008
25MG; 100MG

tablet Prescription ORAL AB Jun 2, 2008
25MG; 250MG

tablet Prescription ORAL AB Jun 2, 2008


Manufacturing Plant Locations
New

Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.

Country City Firm Name
Canada
North York Apotex Inc.
Richmond Hill Apotex Inc.
Toronto Apotex Inc.





7. ASCENT PHARMS INC

Ascent Pharmaceuticals Inc has filed for 3 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG; 100MG

tablet Prescription ORAL AB Jan 14, 2025
10MG; 100MG

tablet Prescription ORAL AB Jan 14, 2025
25MG; 250MG

tablet Prescription ORAL AB Jan 14, 2025





8. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG; 100MG

tablet Prescription ORAL AB Nov 28, 2022
25MG; 100MG

tablet Prescription ORAL AB Nov 28, 2022
25MG; 250MG

tablet Prescription ORAL AB Nov 28, 2022


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





9. DR REDDYS LABS SA

Dr Reddys Laboratories Sa has filed for 3 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG; 100MG

tablet Prescription ORAL AB Aug 28, 1992
25MG; 100MG

tablet Prescription ORAL AB Aug 28, 1992
25MG; 250MG

tablet Prescription ORAL AB Aug 28, 1992





10. IMPAX LABS

Impax Laboratories Inc has filed for 4 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Impax Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG; 200MG

tablet, extended release Prescription ORAL AB May 14, 2004
25MG; 100MG

tablet, orally disintegrating Discontinued ORAL N/A Jun 8, 2010
10MG; 100MG

tablet, orally disintegrating Discontinued ORAL N/A Jun 8, 2010
25MG; 250MG

tablet, orally disintegrating Discontinued ORAL N/A Jun 8, 2010





11. KV PHARM

Kv Pharmaceutical Co has filed for 1 generic for Carbidopa; Levodopa. This 50mg;200mg version comes by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Kv Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG; 200MG

tablet, extended release Discontinued ORAL N/A Jun 24, 2004


Manufacturing Plant Locations
New

Kv Pharm's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Kv Pharm as present at those locations.

Country City Firm Name
United States
Maryland Heights KV Pharmaceutical Co
Saint Louis Kv Pharmaceutical Inc
Brentwood KV Pharmaceutical Co
Saint Louis KV Pharmaceutical Co





12. MYLAN

Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG; 200MG

tablet, extended release Prescription ORAL AB Sep 30, 1999
25MG; 100MG

tablet, extended release Prescription ORAL AB Apr 21, 2000


Manufacturing Plant Locations
New

Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.

Country City Firm Name
United States
San Carlos Mylan Pharmaceuticals Inc.
Saint Albans Mylan Technologies, Inc.
Morgantown Mylan Specialty, L.P.
Santa Barbara Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
Rockford Mylan Institutional, Inc.
Greensboro Mylan Pharmaceuticals Inc
Morgantown MYLAN CONSUMER HEALTHCARE Inc.
India
Hyderabad Mylan Laboratories Limited
Sinnar Mylan Laboratories Limited
Pithampur, District Dhar Mylan Laboratories Limited
Aurangabad Mylan Laboratories Limited (FDF-2)
Sarigam Mylan Laboratories Limited
Hosur Mylan Laboratories Limited
Bangalore Mylan Laboratories Limited
Anekal Taluk, Bangalore Mylan Laboratories Limited
Canada
Etobicoke Mylan Pharmaceuticals ULC
Ireland
Inverin Mylan Teoranta





13. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 3 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG; 100MG

tablet Prescription ORAL AB Sep 28, 2009
25MG; 100MG

tablet Prescription ORAL AB Sep 28, 2009
25MG; 250MG

tablet Prescription ORAL AB Sep 28, 2009





14. RANBAXY

Ranbaxy Laboratories Ltd has filed for 3 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBILEV. Given below are the details of the strengths of this generic introduced by Ranbaxy.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG; 100MG

tablet, for suspension Discontinued ORAL N/A Jun 10, 2005
25MG; 100MG

tablet, for suspension Discontinued ORAL N/A Jun 10, 2005
25MG; 250MG

tablet, for suspension Discontinued ORAL N/A Jun 10, 2005


Manufacturing Plant Locations
New

Ranbaxy's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Ranbaxy as present at those locations.

Country City Firm Name
United States
Princeton Ranbaxy Inc.





15. RISING

Rising Pharma Holding Inc has filed for 3 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG; 100MG

tablet, orally disintegrating Discontinued ORAL N/A Sep 18, 2008
25MG; 250MG

tablet, orally disintegrating Discontinued ORAL N/A Sep 18, 2008
25MG; 100MG

tablet, orally disintegrating Discontinued ORAL N/A Sep 18, 2008


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Saddle Brook Rising Pharmaceuticals, Inc.
Decatur Rising Pharma Holdings, Inc
Rising Sun Rising Sun Veterinary Clinic
Fort Bragg Rising Tide Sea Vegetables
Livingston Risingsun Iodine Products Corp.
Mount Morris Rising Creek Bakery LLC
Phoenix Rising Sun Farms Inc
East Brunswick Rising Pharma Holding, Inc.
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





16. RUBICON

Rubicon Research Private Ltd has filed for 4 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Rubicon.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG; 100MG

tablet Prescription ORAL AB Sep 21, 2022
25MG; 250MG

tablet Prescription ORAL AB Sep 21, 2022
25MG; 100MG

tablet, extended release Prescription ORAL AB Jun 4, 2024
50MG; 200MG

tablet, extended release Prescription ORAL AB Jun 4, 2024


Manufacturing Plant Locations
New

Rubicon's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Rubicon as present at those locations.

Country City Firm Name
United States
Geismar Rubicon, LLC
Indianapolis Rubicon Foods LLC
Canada
Concord Rubicon Research Canada Limited
India
Ambarnath Rubicon Research Private Limited





17. SANDOZ

Sandoz Inc has filed for 2 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG; 100MG

tablet Discontinued ORAL N/A Jun 29, 1995
25MG; 250MG

tablet Discontinued ORAL N/A Jun 29, 1995


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Langkampfen Sandoz GmbH
Kundl Sandoz GmbH
United States
East Hanover Sandoz Incorporated
Princeton Sandoz Inc
Spain
Les Franqueses Del Valles Sandoz Industrial Products S.A.
Palafolls Sandoz Industrial Products, S.A.
India
Navi Mumbai Sandoz Private Limited





18. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 4 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG; 250MG

tablet Prescription ORAL AB May 7, 2021
10MG; 100MG

tablet Prescription ORAL AB May 7, 2021
25MG; 100MG

tablet, extended release Prescription ORAL AB Oct 5, 2021
50MG; 200MG

(reference standard)

tablet, extended release Prescription ORAL AB Oct 5, 2021





19. SCS

Scs Pharmaceuticals has filed for 3 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Scs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG; 100MG

tablet Discontinued ORAL N/A Mar 25, 1994
25MG; 250MG

tablet Discontinued ORAL N/A Mar 25, 1994
25MG; 100MG

tablet Discontinued ORAL N/A Mar 25, 1994


Manufacturing Plant Locations
New

Scs's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Scs as present at those locations.

Country City Firm Name
United States
Royal Oaks SCS Cold Storage Inc
Trumbull SCS Direct Inc.





20. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG; 100MG

tablet, orally disintegrating Prescription ORAL N/A Jul 31, 2009
10MG; 100MG

tablet, orally disintegrating Prescription ORAL N/A Jul 31, 2009
25MG; 250MG

(reference standard)

tablet, orally disintegrating Prescription ORAL N/A Jul 31, 2009


Manufacturing Plant Locations
New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country City Firm Name
United States
Billerica Sun Pharmaceutical Industries, Inc.
Lexington Sun Pharmaceutical Industries Inc
Princeton SUN PHARMACEUTICAL INDUSTRIES INC
India
Punjab Sun Pharmaceutical Industries, Inc.
Dadra Sun Pharmaceutical Industries Limited
Kanchipuram Sun Pharmaceutical Industries Limited- Madhuranthagam
Halol Sun Pharmaceutical Industries Ltd.
Vadodara Sun Pharmaceutical Industries Ltd
Baruch Sun Pharmaceutical Industries Ltd.
Vadodara Sun Pharmaceutical Industries Ltd.
Bharuch Sun Pharmaceutical Industries Ltd
Malanpur, Bhind (District) Sun Pharmaceutical Industries Limited
Mohali Sun Pharmaceutical Industries Limited
Ahmednagar Sun Pharmaceutical Industries Limited
Gurugram Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
New Delhi Sun Pharmaceutical Industries Limited
Vadodara Sun Pharmaceutical Industries Limited - Karkhadi





21. SUN PHARM INDS

Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG; 100MG

tablet Prescription ORAL AB Oct 28, 2008
50MG; 200MG

tablet, extended release Prescription ORAL AB Aug 23, 2007
10MG; 100MG

tablet Prescription ORAL AB Oct 28, 2008
25MG; 250MG

tablet Prescription ORAL AB Oct 28, 2008





22. UCB INC

Ucb Inc has filed for 3 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name PARCOPA. Given below are the details of the strengths of this generic introduced by Ucb Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG; 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

tablet, orally disintegrating Discontinued ORAL N/A Aug 27, 2004
25MG; 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

tablet, orally disintegrating Discontinued ORAL N/A Aug 27, 2004
25MG; 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

tablet, orally disintegrating Discontinued ORAL N/A Aug 27, 2004





23. WATSON LABS

Watson Laboratories Inc has filed for 3 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG; 250MG

tablet Discontinued ORAL N/A Sep 28, 1993
10MG; 100MG

tablet Discontinued ORAL N/A Sep 28, 1993
25MG; 100MG

tablet Discontinued ORAL N/A Sep 28, 1993





24. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Carbidopa; Levodopa. All of these versions come by the name CARBIDOPA AND LEVODOPA. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG; 100MG

tablet Discontinued ORAL N/A Apr 4, 2023
25MG; 250MG

tablet Discontinued ORAL N/A Apr 4, 2023
25MG; 100MG

tablet Discontinued ORAL N/A Apr 4, 2023